Follow
Guillaume Desachy
Guillaume Desachy
Statistical Science Director, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Autism traits in the RASopathies
B Adviento, IL Corbin, F Widjaja, G Desachy, N Enrique, T Rosser, S Risi, ...
Journal of medical genetics 51 (1), 10-20, 2014
1692014
Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells
M Bershteyn, Y Hayashi, G Desachy, EC Hsiao, S Sami, KM Tsang, ...
Nature 507 (7490), 99-103, 2014
1042014
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
P Soret, C Le Dantec, E Desvaux, N Foulquier, B Chassagnol, S Hubert, ...
Nature communications 12 (1), 3523, 2021
922021
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
HG Nüßlein, R Alten, M Galeazzi, HM Lorenz, MT Nurmohamed, ...
BMC Musculoskeletal Disorders 16 (1), 1-11, 2015
542015
Increased female autosomal burden of rare copy number variants in human populations and in autism families
G Desachy, LA Croen, AR Torres, M Kharrazi, GN Delorenze, ...
Molecular psychiatry 20 (2), 170-175, 2015
542015
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study
HG Nüßlein, R Alten, M Galeazzi, HM Lorenz, MT Nurmohamed, ...
Clin Exp Rheumatol 34 (3), 489-499, 2016
452016
Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn’s disease
G Chevalier, A Laveissière, G Desachy, N Barnich, A Sivignon, ...
Microbiome 9, 1-16, 2021
282021
First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours
J Rodon, S Postel-Vinay, A Hollebecque, P Nuciforo, A Azaro, V Cattan, ...
European Journal of Cancer 81, 142-150, 2017
272017
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
R Alten, H Nüßlein, M Galeazzi, HM Lorenz, MT Nurmohamed, ...
RMD open 2 (1), e000228, 2016
172016
Baseline autoantibodies preferentially impact abatacept efficacy in patients with RA who are biologic naïve: 6-month results from a real-world, international, prospective study
R Alten, H Nüßlein, M Galeazzi, HM Lorenz, X Mariette, A Cantagrel, ...
Arthritis Rheumatol 67 (Suppl 10), 465, 2015
22015
Baseline autoantibodies preferentially impact abatacept efficacy in patients with RA who are biologic naïve: 6-month results from a real-world, international, prospective study
R Alten, H Nuesslein, M Galeazzi, H Lorenz, X Mariette, A Cantagrel, ...
Arthritis Rheumatol 67 (Suppl 10), 465, 2015
22015
Droplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer
E Van Cutsem, K Lesniewski-Kmak, MP Saunders, H Wasan, G Argiles, ...
Annals of Oncology 29, viii181, 2018
12018
Body mass index does not influence the efficacy of abatacept in patients with RA who are biologic Naïve: 6-month results from a real-world, international, prospective study
R Alten, HG Nuesslein, M Galeazzi, HM Lorenz, X Mariette, A Cantagrel, ...
ARTHRITIS & RHEUMATOLOGY 67, 2015
12015
Sharing recruitment sites with a precision-medicine based study
A Mahmutovic, A Harper, G Desachy, J Tillinghast, J Cooper
European Respiratory Journal 62 (suppl 67), 2023
2023
Disarming E. coli linked to Crohn’s disease
G Chevalier, A Laveissière, G Desachy, N Barnich, A Sivignon, ...
2021
BASELINE AUTOANTIBODIES PREFERENTIALLY IMPACT ABATACEPT EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE BIOLOGIC NAIVE: 6-MONTH RESULTS FROM A REAL-WORLD, INTERNATIONAL …
R Alten, H Nuesslein, M Galeazzi, HM Lorenz, X Mariette, A Cantagrel, ...
RHEUMATOLOGY 55, 94-94, 2016
2016
080 Baseline Autoantibodies Preferentially Impact Abatacept Efficacy in Patients with Rheumatoid Arthritis who are Biologic Naive: 6-Month Results from a Real-World …
R Alten, H Nüßlein, M Galeazzi, HM Lorenz, X Mariette, A Cantagrel, ...
Rheumatology 55 (suppl_1), i94-i94, 2016
2016
Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells
A Kriegstein, E Hsiao, L Weiss, M Bershteyn, Y Hayashi, G Desachy, ...
2014
COMPOSITIONS AND METHODS FOR IDENTIFYING AGENTS THAT MODULATE IGE PRODUCTION AND MAST CELL DEGRANULATION (SF00-074 SF98-005)
C Links, G Desachy, I Corbin, J Quinn, K Tsang, L Weiss
The system can't perform the operation now. Try again later.
Articles 1–19